Ticker Details
Alumis Inc. Common Stock
IPO Date:	June 28, 2024
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$3.13B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.54 | 4.70%
Avg Daily Range (30 D):	$0.95 | 3.50%
Avg Daily Range (90 D):	$0.85 | 3.40%

Institutional Daily Volume
Avg Daily Volume:	.86M
Avg Daily Volume (30 D):	.79M
Avg Daily Volume (90 D):	.98M

Trade Size
Avg Trade Size (Sh.):	80
Avg Trade Size (Sh.) (30 D):	54
Avg Trade Size (Sh.) (90 D):	57

Institutional Trades
Total Institutional Trades:	542
Avg Institutional Trade:	$2.29M
Avg Institutional Trade (30 D):	$2.53M
Avg Institutional Trade (90 D):	$2.9M
Avg Institutional Trade Volume:	.11M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$4.09M
Avg Closing Trade (30 D):	$3.88M
Avg Closing Trade (90 D):	$4.79M
Avg Closing Volume:	191.86K

News

May 17, 2026 @ 6:13 PM Alumis Stock Has Soared 400%. Cormorant Bought Ano... Source: Jonathan Ponciano

Apr 14, 2026 @ 5:00 PM The Psoriasis Clinical Trial Pipeline Boom as 90+ ... Source: Delveinsight

Mar 28, 2026 @ 5:30 PM Alumis’ Envudeucitinib Delivers Early and R... Source: Na

Jan 8, 2026 @ 3:52 AM Alumis Announces Pricing of Upsized Public Offerin... Source: Na

Jan 6, 2026 @ 10:12 PM Stock Market Today, Jan. 6: Alumis Shares Surge on... Source: Howard Smith

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$-3.85	$-1.11	$-.74
Diluted EPS	$-3.85	$-1.11	$-.74
Revenue	$7.4M	$1.66M	$1.74M
Gross Profit
Net Income / Loss	$-438.96M	$-142.22M	$-93.05M
Operating Income / Loss	$-459M	$-148.86M	$-98.41M
Cost of Revenue
Net Cash Flow	$-88.41M	$-.18M	$-25.78M
PE Ratio